Myc is both a Lin28b target and a regulator of its expression,71,114–116 and so it remains unclear whether the increased expression of Myc in the Rpl22-deficient AML is the cause or a result of Lin28b induction. This evidence concerns the gene RPL22 and acute myeloid leukemia.